Fraunhofer Institute for Cell Therapy and Immunology IZI

Leipzig Immune ONcology (LION) Conference

Virtual conference | November 9–10, 2021 | Registration is open. For the latest conference updates sign up for our newsletter.

more info
Frank-Holm Rögner of Fraunhofer FEP, Martin Thoma of Fraunhofer IPA, and PD Dr. Sebastian Ulbert and Dr. Jasmin Fertey of Fraunhofer IZI (from left to right) are awarded the Fraunhofer Prize "Technology for People and their Environment" 2021 for a more efficient, faster and environmentally friendly manufacturing process for vaccines.
© Fraunhofer / Piotr Banczerowski

Fraunhofer Prize for “Human- and Environment-Centered Technology” 2021

more info

We transfer biomedical research into the clinic.

The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops solutions to specific problems at the interfaces of medicine, life sciences and engineering. One of the institute‘s main tasks is to conduct contract research for companies, hospitals, diagnostic laboratories and research institutes operating in the field of biotechnology, pharma­ceuticals and medical engineering.

The Fraunhofer IZI develops, optimizes and validates methods, materials and products within the business fields cell and gene therapy, drugs and vaccines, molecular diagnostics and immunodiagnostics, as well as extracorporeal therapies. Its areas of competence lie in cell biology, immunology, drug biochemistry, bioanalytics and bioproduction as well as process development and automation. Research in these areas is centered around developments in immuno-oncology and infectious disease pathology. The S3 safety laboratory allows research and development activities to be conducted and highly pathogenic agents investigated under biosafety level 3 conditions.

The institute works in close cooperation with hospital institutions and performs quality tests besides manufacturing investigational medicinal products in line with GMP requirements. Furthermore, it supports partners in developing processes for the pharmaceutical production of ATMPs and biologicals, for example by helping them to obtain manufacturing licenses.

News

Latest press releases

25.5.2021

Anhalt University of Applied Sciences and Fraunhofer IZI open joint research laboratory for natural product-based therapeutics

Are algae the superfood and active ingredient suppliers of the future? Under the direction of Professor Carola Griehl, researchers at the Competence Center Algal Biotechnology at Anhalt University of Applied Sciences have been working on this question for many years. On May 27, 2021 the Anhalt University of Applied Sciences and the Fraunhofer Institute for Cell Therapy and Immunology IZI open the Center for Natural Product-Based Therapeutics (ZNT). In addition to the invited guests on site, all interested parties are invited via live stream to the ceremonial opening.
Read more

21.5.2021

Simplified method developed for monitoring CAR T-cell therapies using flow cytometry

CAR T-cell therapy, a novel cancer immunotherapy, uses patients' own T cells, which have been genetically engineered, for treatment. Currently, this therapy is used for some forms of blood cancer and lymphoma. In order to assess both the success and side effects of CAR T-cell therapies, intensive monitoring after administration is necessary.
Read more

10.5.2021

Researchers aim at developing a vaccine protecting against urinary tract infection

From a Danish-German consortium intend to develop a vaccine protecting against urinary tract infection. The SVEET project (Sugar-modified Vaccine Epitopes; Exploration and Translation) is funded by the German DLR and the Innovation Fund Denmark with 702,800 Euro within the eurostars® programme.
Read more

5.5.2021

Fraunhofer Prize for “Human- and Environment-Centered Technology” 2021 for a vaccine production process that is faster, more efficient and more environmentally friendly

Vaccines are currently a great source of hope for many people, as it is believed they will help to protect society against COVID-19 and pave the way back to a normal life. The current focus is clearly on coronavirus — but vaccines are also fundamental to combating other pathogens. A team of researchers from three Fraunhofer Institutes has now developed a method of producing vaccines that is faster, more efficient and more environmentally friendly than the conventional production process — and their efforts have earned them the Fraunhofer Prize for “Human- and Environment-Centered Technology”. The award ceremony took place during the annual conference of the Fraunhofer-Gesellschaft on May 5, 2021.
Read more

Press / media

 

As an institution of application-oriented research, the Fraunhofer Institute for Cell Therapy and Immunology IZI attaches great importance to informing customers and the public.

Events

 

The Fraunhofer IZI offers its partners and guests space for communication.

Utilize our modern and representative premises for your event. The generously proportioned and modern space offered at the Institute provides space for, e. g., workshops, symposia, conferences and lectures.

 

 

Fraunhofer Prize for “Human- and Environment-Centered Technology” 2021

For a vaccine production process that is faster, more efficient and more environmentally friendly.

 

November 9-10, 2021 | Virtual conference

Leipzig Immune ONcology Conference (LION)

The LION Conference will bring together clinicians, scientists and industry to discuss latest developments and highlights on special issues of immune oncology.

 

United against Corona

 

Annual report 2020

The annual report gives you an insight into the structure of the Fraunhofer IZI, our services, important events and publications, offers, as well as selected project examples.

Research projects funded by the EU

Research projects at Fraunhofer IZI that are supported by the Land of Saxony / Saxony-Anhalt / Mecklenburg-Western Pomerania using funds provided by the European Regional Development Fund (ERDF).

 

Business units and core competencies

The Fraunhofer IZI offers R&D services for pharmaceutical, biotechnological and medical technology companies as well as for partners from research institutions, hospitals and diagnostic laboratories.

Jobs / career

We keep you informed on current job offers at the Fraunhofer IZI. Find out about the possibilities the Fraunhofer-Gesellschaft could offer you as an employer.

Publications

We gladly provide our clients and partners as well as the interested public with information on our research activities.

 

Contact

Fraunhofer IZI

 

Perlickstraße 1
04103 Leipzig
Germany

Phone +49 341 35536-1000
Fax +49 341 35536-8-1000

 

Social Media